(Q39467426)

12 September 2017

title

Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathy (English)

1 reference

12 September 2017

B V Jensen

1

1 reference

12 September 2017

S L Nielsen

series ordinal

2

1 reference

12 September 2017

T Skovsgaard

series ordinal

3

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 February 1996

1 reference

12 September 2017

1 reference

12 September 2017

volume

347

1 reference

12 September 2017

issue

8997

1 reference

12 September 2017

page(s)

297-299

1 reference

Risk factors for doxorubicin-induced congestive heart failure

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990469-9

7 January 2021

Epirubicin cardiotoxicity: a study of 135 patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990469-9

7 January 2021

A clinicopathologic analysis of adriamycin cardiotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990469-9

7 January 2021

Doxorubicin-induced congestive heart failure in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990469-9

7 January 2021

Adriamycin cardiomyopathy--risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990469-9

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990469-9

7 January 2021

Right and left ventricular ejection fraction and left ventricular volume changes at rest and during exercise in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990469-9

7 January 2021

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990469-9

7 January 2021

10.1016/S0140-6736(96)90469-9

Identifiers

DOI

1 reference

12 September 2017

1 reference